Industry Conference

BridgeBio Oncology's new drug candidate BBO-10203 could redefine cancer therapy by avoiding a key toxicity, unlocking a vast market.

A major tech conference highlights a critical global skills gap in AI and security. Is Canadian policy ready for the infrastructure of tomorrow?

Beyond the dazzling lights, Seattle's iconic New Year's Eve show is a calculated investment in branding, technology, and regional economic dominance.

Helium's decentralized wireless network is expanding to Brazil, testing a "people-powered" model to bridge the digital divide. Can it disrupt big telco?

Behind EVs, AI, and medical breakthroughs lies a hidden process. Discover how ion implantation shapes the chips that power our future and our trust in it.

New data shows Kazia's paxalisib dismantles metastatic drivers and reignites immunity, signaling a strategic disruption in advanced breast cancer treatment.

As AI transforms software development, a new security blind spot emerges. Discover how one company is tackling threats at the heart of AI-native coding.

A Chinese biotech is pioneering next-gen cancer drugs that promise higher precision and fewer side effects. Is this the future of oncology treatment?

As EMEA faces a critical tech skills shortage, Skillsoft’s AWS award reveals a proven blueprint for building the cloud and AI workforce of the future.

Beyond smart homes lies the autonomous estate. Discover how Web3, AI, and decentralized networks are redefining privacy and management in luxury real estate.

Stunning trial data reveals an immunotherapy combo that slashes myeloma progression by 83%, offering not just longer life but a better quality of life.

Tempus AI's research at a key symposium shows its AI-driven edge, turning vast patient data into a powerful asset that could reshape oncology and investor outlooks.

A partnership between ZEDEDA and Sonny's Enterprises reveals how edge orchestration is transforming traditional industry and creating a blueprint for the future.

The biotech is advancing a promising myelofibrosis therapy while developing a next-gen 'super drug,' a dual strategy signaling significant growth.

As the aging U.S. grid strains under explosive demand, industrial leaders are turning to microgrids for energy independence and financial stability.

Ancient Hakka Tulou are more than relics. Discover how these UNESCO sites blend tradition with tech to create a sustainable tourism model for the future.

John Crowley, who fought to save his own children, will now shape the future of medicine as he headlines the landmark 2026 MDA conference.

How a Japanese labor firm is leveraging traditional osteopathy and high-profile sports events to execute an ambitious global expansion strategy.

Fate Therapeutics' latest data suggests its iPSC-derived CAR-T could revolutionize lupus care, moving cell therapy beyond cancer and into the mainstream.

FBI data shows most active threats begin outdoors. New tech is extending security beyond the building, creating an integrated, automated defense.